MORRISTOWN, N.J., Sept. 23, 2025 /PRNewswire/ -- Alvogen Pharma US, Inc. ("Alvogen"), a privately owned US-based pharmaceutical company, today announced a definitive agreement by its shareholders to ...
Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. ("Alvogen” or the "Company”), a privately owned US-based pharmaceutical company, has completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback